Recursion Pharmaceuticals, Inc. Class A (RXRX)
NASDAQ · Manufacturing · Biological products, (no diagnostic substances)
$3.77−$0.1200 (−3.08%) on the dayAs of the close; data may be delayed.
RXRX price, last 12 months
Key stats
- Previous close
- $3.89
- Open
- $3.92
- Day range
- $3.70 – $3.94
- 52-week range
- $2.77 – $7.18
- Volume
- 9.6M
- Avg volume (20 days)
- 19.3M
- Market cap
- $2.0B
Performance
1W−1.6%
1M+8.0%
3M+7.1%
6M+19.7%
YTD−7.8%
1Y−22.8%
vs S&P 500, 1Y−39.5 pts
Technicals and fundamentals
About Recursion Pharmaceuticals, Inc. Class A
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.
- Sector
- Manufacturing
- Industry
- Biological products, (no diagnostic substances)
- Listed on
- NASDAQ
- Market cap
- $2.0B